Josh Archambault, MPP, is a Senior Fellow at the Foundation for Government Accountability
Prior to joining FGA, Josh served as the director of the Center for Healthcare Solutions and as program manager for the Middle Cities Initiative at Pioneer Institute, a Boston-based think tank. While at Pioneer he co-authored the nationally acclaimed book The Great Experiment: The States, The Feds, and Your Healthcare (2012) and published numerous studies on the potential impact of payment and delivery system reform proposals on patients and Obamacare’s impact on Massachusetts residents and businesses. He has testified before several state legislative committees and before the U.S. House of Representatives’ Committee on Energy and Commerce’s Subcommittee on Health.
Josh was previously selected as a health policy fellow at the Heritage Foundation in Washington, D.C., where his research concentrated on the impact of Obamacare on small businesses and the lessons that could be learned from the Massachusetts experiment.
In the past, Josh served as a legislative director in the Massachusetts State Senate for Scott Brown and as senior legislative aide for then-Governor Mitt Romney in his Office of Legislative Affairs.
Josh’s work has earned coverage in outlets including the Wall Street Journal, USA Today, The New York Times, Fox News, NPR, Money Magazine, and National Review Online. He is also a regular contributor to the influential Forbes.com blog, The Apothecary.
Josh holds a master’s in public policy from Harvard University’s Kennedy School of Government and a B.A. in political studies and economics from Gordon College.
Recent Posts by Josh Archambault
An amendment to the AHCA draws in part from a proposal to include an invisible high-risk pool. Based on an independent analysis, there are a few misconceptions that should be corrected and changes that could improve the invisible risk-sharing program.
Maine’s experience in creating an invisible high-risk pool and relaxing its premium rating bands can inform Congress and the Trump administration as they work to repeal and replace the ACA.
Will Section 1332 waivers be as truly transformative to our health care system? A serious, objective examination of the new Section 1332 federal guidance provides far more questions than answers for policymakers.